Skip to content
TrialScanner

NCT05953688

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Phase 2TerminatedALMSLead

Registry record

Lead sponsor
Alumis Inc
Conditions
Uveitis Posterior Non-Infectious; Uveitis, Intermediate; Noninfectious Panuveitis
Primary completion
Aug 13, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05953688 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05953688: POC Study to Evaluate the... | TrialScanner